Embecta Corp (EMBC NASDAQ) stock market data APIs
$8.7889
-0.14(-1.6%)
as of April 2, 2026
Try our APIs with
free plan!
Embecta Corp Financial Data Overview
Price chart is built with
Anychart
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Prev. Close
8.7889
Open
8.6528
High
8.9434
Low
8.5673
52 wk Range
8.47-15.1306
Market Cap
524 M
P/E Ratio
3.75
Shares Outstanding
59 220 K
Revenue
1 080 M
EPS
0.71
Dividends (Yield)
0.0683
Beta
1.101
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Embecta Corp (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Embecta Corp data using free add-ons & libraries
Get Embecta Corp Fundamental Data
Embecta Corp Fundamental data includes:
- Net Revenue: 1 080 M
- EBITDA: 367 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-05
- EPS/Forecast: 0.67
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Embecta Corp News
New
Embecta to Acquire Owen Mumford to Expand Drug-Delivery Portfolio
Embecta Corp. EMBC recently announced a definitive agreement to acquire Owen Mumford Holdings Limited, a pioneer in developing advanced drug delivery systems and medical device solutions, making a str...
Embecta agrees to acquire Owen Mumford
Embecta has signed a definitive agreement to acquire UK-based Owen Mumford Holdings for up to £150m ($172.6m), to enhance its global presence in drug delivery technologies. The agreement includes an...
Embecta to buy Owen Mumford for up to $201M
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dive Brief: Diabetes care firm Embecta reached an agreem...
embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited
PARSIPPANY, N.J., March 19, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“Embecta”) (Nasdaq: EMBC), a global leader in diabetes care technology, today announced that it has entered into a definitive ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
